Sort
40,608 grants matching “prostate cancer”
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2
$371,816David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · CA
Effects of Lycopene on High-Risk Prostatic Tissue
$371,803Northwestern University · R01 · FY2004 · CA
Prostate Cancer Studies
$371,781Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Role of MED1 in the AR-dependent transcription in advanced prostate cancer
$371,719Irfan Ahmed Asangani · University Of Pennsylvania · R01 · FY2022 · CA
Towards characterization of Epigenetic targets in Prostate Cancer
$371,719Irfan Ahmed Asangani · University Of Pennsylvania · R01 · FY2025 · CA
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
$371,704Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2018 · CA
Project 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate Cancer
$371,701Brett Stewart Carver · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer
$371,700David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Sympathetic modulation of head and neck cancer pain
$371,688Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DE
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer
$371,679Jeremy James Johnson · University Of Illinois At Chicago · R37 · FY2025 · CA
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer
$371,677Jeremy James Johnson · University Of Illinois At Chicago · R37 · FY2024 · CA
INTERVENTION DEVELOPMENT AND MEASUREMENT
$371,673Suzanne M Miller · University Of Colorado Denver · P01 · FY2010 · CA
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2
$371,660David A Guertin · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · CA
Androgen Signaling in Neoplastic Prostate Growth
$371,656Peter S Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2006 · DK
Ethnic Differences in Media Response and Recruitment
$371,644Deborah W Bruner · University Of Pennsylvania · R01 · FY2007 · CA
Cross-sectional and prospective cohort data analysis of physical activity and hea
$371,558Paul T Williams · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2011 · HL
Data acquisition system for noninvasive cancer detection
$371,556Boris Gorbovitski · Biophotonics Corporation · R42 · FY2006 · CA
Project 3: Towards Understanding Prostate Cancer Heterogeneity
$371,556Mark A. Rubin · Weill Medical Coll Of Cornell Univ · P50 · FY2017 · CA
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
$371,532John V Frangioni · Curadel, Llc · R01 · FY2013 · EB
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Roles of EAF2 in androgen action in the prostate
$371,525Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Targeted delivery of multimodal therapy for reducing prostate cancer disparity
$371,500Runhua Runa Liu · University Of Alabama At Birmingham · R01 · FY2023 · CA
Dose-Response in Radionuclide Therapy
$371,497George Sgouros · Johns Hopkins University · R01 · FY2011 · CA